The significance of maximum standardized uptake values in patients with stage I pulmonary adenocarcinoma

European Journal of Cardio-thoracic Surgery

Volumn 35, Issue 4, 2009, Pages 712-717

  Kim, Hyeong Ryul ^a   Kim, Dong Jin ^a   Lee, Won Woo ^a   Jheon, Sanghoon ^a   Sung, Sook Whan ^a  

^a Seoul National University Bundang Hospital   (South Korea)

Author keywords

Adenocarcinoma; Disease free survival; FDG PET; Non small cell lung cancer; Prognosis; SUV

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; LOBECTOMY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; EPIDEMIOLOGIC METHODS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RECURRENCE; YOUNG ADULT;

EID: 62149100740     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2008.12.030     Document Type: Article

References (21)

1. Kopp R., Weidenhagen R., Reinmiedl J., Müller C., Fürst H., Bittmann I., Dienemann H., and Hatz R. Outcome following lung resections for pT1 non-small cell lung cancer. Eur J Surg Oncol 32 (2006) 329-334
2. Duhaylongsod F.G., Lowe V.J., Patz Jr. E.F., Vaughn A.L., Coleman R.E., and Wolfe W.G. Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography. Ann Thorac Surg 60 (1995) 1348-1352
3. Patronas N.J., Di Chiro G., Kufta C., Bairamian D., Kornblith P.L., Simon R., and Larson S.M. Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 62 (1985) 816-822
4. Okada J., Oonishi H., Yoshikawa K., Itami J., Uno K., Imaseki K., and Arimizu N. FDG-PET for predicting the prognosis of malignant lymphoma. Ann Nucl Med 8 (1994) 187-191
5. 18F-fluorodeoxyglucose positron emission tomography and the prognosis of patients with pancreatic adenocarcinoma. Cancer 79 (1997) 695-699
6. Nuutinen J., Leskinen S., Lindholm P., Söderström K.O., Någren K., Huhtala S., and Minn H. Use of carbon-11 methionine positron emission tomography to assess malignancy grade and predict survival in patients with lymphomas. Eur J Nucl Med 25 (1998) 729-735
7. 18F-labeled fluorouracil positron emission tomography and the prognoses of colorectal carcinoma patients with metastases to the liver treated with 5-fluorouracil. Cancer 83 (1998) 245-253
8. Bénard F., Sterman D., Smith R.J., Kaiser L.R., Albelda S.M., and Alavi A. Prognostic value of FDG PET imaging in malignant pleural mesothelioma. J Nucl Med 40 (1999) 1241-1245
9. Folpe A.L., Lyles R.H., Sprouse J.T., Conrad III E.U., and Eary J.F. (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. Clin Cancer Res 6 (2000) 1279-1287
10. Younes M., Brown R.W., Stephenson M., Gondo M., and Caqle P.T. Overexpression of Glut-1 and Glut3 in stage I non-small cell lung carcinoma is associated with poor survival. Cancer 80 (1997) 1046-1051
11. Ahuja V., Coleman R.E., Herndon J., and Patz Jr. E.F. The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with non-small cell lung carcinoma. Cancer 83 (1998) 918-924
12. Vansteenkiste J.F., Stroobants S.G., Dupont P.J., De Leyn P.R., Verbeken E.K., Deneffe G.J., Mortelmans L.A., Demedts M.G., and Leuven Lung Cancer Group. Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small cell lung cancer: an analysis of 125 cases. J Clin Oncol 17 (1999) 3201-3206
13. Nguyen X.C., Lee W.W., Chung J.H., Park S.Y., Sung S.W., Kim Y.K., So Y., Lee D.S., Chung J.K., Lee M.C., and Kim S.E. FDG uptake, glucose transporter type 1, and Ki-67 expressions in non-small-cell lung cancer: correlations and prognostic values. Eur J Radiol 62 (2007) 214-219
14. 18F- FDG Uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer. J Nucl Med 43 (2002) 39-45
15. Downey R.J., Akhurst T., Gonen M., Vincent A., Bains M.S., Larson S., and Rusch V. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximum standardized uptake value predicts survival after lung cancer resection. J Clin Oncol 22 (2004) 3255-3260
16. Cerfolio R.J., Bryant A.S., Ohja B., and Bartolucci A.A. The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival. J Thorac Cardiovasc Surg 130 (2005) 151-159
17. Kieninger A.N., Welsh R., Bendick P.J., Zelenock G., and Chmielewski G.W. Positron-emission tomography as a prognostic tool for early-stage lung cancer. Am J Surg 191 (2006) 433-436
18. Borst G.R., Belderbos J.S., Boellaard R., Comans E.F., De Jaeger K., Lammertsma A.A., and Lebesque J.V. Standardised FDG uptake: a prognostic factor for inoperable non-small cell lung cancer. Eur J Cancer 41 (2005) 1533-1541
19. Davies A., Tan C., Paschalides C., Barrington S.F., O'Doherty M., Utley M., and Treasure T. FDG-PET maximum standardised uptake value is associated with variation in survival: analysis of 498 lung cancer patients. Lung Cancer 55 (2007) 75-78
20. Downey R.J., Akhurst T., Gonen M., Vincent A., Bains M.S., Larson S., and Rusch V. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. J Clin Oncol 22 (2004) 3255-3260
21. van Baardwijk A., Dooms C., van Suylen R.J., Verbeken E., Hochstenbag M., Dehing-Oberije C., Rupa D., Pastorekova S., Stroobants S., Buell U., Lambin P., Vansteenkiste J., and De Ruysscher D. The maximum uptake of 18F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1a and GLUT-1 in non-small cell lung cancer. Eur J Cancer 43 (2007) 1392-1398